Technical Analysis for RX - BioSyent Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 8.510 | 1.31% | 0.110 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | 1.31% | |
| 50 DMA Resistance | Bearish | 1.31% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 8 hours ago |
| Possible Inside Day | about 8 hours ago |
| Possible NR7 | about 8 hours ago |
| Possible Pocket Pivot | about 10 hours ago |
| Up 1 ATR | about 10 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-05-24
BioSyent Inc. Description
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc., acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women's Health Unit, which commercializes pharmaceutical products focused on improving family and women's health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. Cathejell is indicated for surface anesthesia and lubrication for various procedures. RepaGyn helps relieve dryness and promotes healing of the vaginal mucosa. It also manufactures and markets Protect-It, a non-toxic product.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharma Pharmaceutical Pharmaceutical Products Anemia Cnx Nifty Iron Deficiency
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.26 |
| 52 Week Low | 7.03 |
| Average Volume | 6,468 |
| 200-Day Moving Average | 8.228 |
| 50-Day Moving Average | 8.603 |
| 20-Day Moving Average | 8.570 |
| 10-Day Moving Average | 8.505 |
| Average True Range | 0.107 |
| RSI (14) | 46.52 |
| ADX | 13.89 |
| +DI | 20.150 |
| -DI | 22.877 |
| Chandelier Exit (Long, 3 ATRs) | 8.430 |
| Chandelier Exit (Short, 3 ATRs) | 8.720 |
| Upper Bollinger Bands | 8.758 |
| Lower Bollinger Band | 8.381 |
| Percent B (%b) | 0.34 |
| BandWidth | 4.397 |
| MACD Line | -0.050 |
| MACD Signal Line | -0.034 |
| MACD Histogram | -0.0165 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.525 | ||||
| Resistance 3 (R3) | 8.523 | 8.517 | 8.523 | ||
| Resistance 2 (R2) | 8.517 | 8.513 | 8.518 | 8.522 | |
| Resistance 1 (R1) | 8.513 | 8.510 | 8.515 | 8.515 | 8.521 |
| Pivot Point | 8.507 | 8.507 | 8.508 | 8.508 | 8.507 |
| Support 1 (S1) | 8.503 | 8.503 | 8.505 | 8.505 | 8.499 |
| Support 2 (S2) | 8.497 | 8.500 | 8.498 | 8.498 | |
| Support 3 (S3) | 8.493 | 8.497 | 8.498 | ||
| Support 4 (S4) | 8.495 |
